Literature DB >> 25315968

Efficacy of photodynamic therapy in the management of oral premalignant lesions. A systematic review.

Fahim Vohra1, Abdulaziz A Al-Kheraif2, Talat Qadri3, Mohamed Ibrahim Abu Hassan4, Asma Ahmed5, Saman Warnakulasuriya6, Fawad Javed7.   

Abstract

OBJECTIVE: The aim was to systematically review the efficacy of photodynamic therapy (PDT) in the management of oral premalignant lesions.
METHODS: The addressed focused question was "Is PDT effective in the management of oral premalignant lesions?" PubMed/Medline, Google-Scholar, EMBASE and ISI Web of Knowledge databases were searched from 1984 till June 2014 using different combinations of the following keywords: photodynamic therapy; oral premalignant lesions; leukoplakia; erythroplakia; erythro-leukoplakia; verrucous hyperplasia; and submucous fibrosis. Review articles, experimental studies, case-reports, commentaries, letters to the Editor, unpublished articles and articles published in languages other than English were not sought. The pattern of the present study was customized to mainly summarize the relevant information.
RESULTS: Thirteen studies were included. In these studies, the number of patients ranged between 5 patients and 147 individuals with mean ages ranging between 51 years and 62.2 years. Oral premalignant lesions, which were investigated were leukoplakia, erythroplakia, erythro-leukoplakia and verrucous hyperplasia. Reported number of premalignant lesions ranged between 5 and 225. Laser wavelength, duration of irradiation and power density were 585-660nm, 60s to 16.6min and 100-150mW/cm(2), respectively. Aminolevulinic acid, chlorine-e6, meta-tetrahydroxyphenylchlorin and photofrin were used as photosensitizer. The frequency of PDT application ranged between once and 12 times. Complete, partial and no response to PDT was shown by 27-100%, 5-50% and 0-25% of pre-malignant lesions, respectively. The recurrence rate of pre-malignant lesions was up to 36%.
CONCLUSION: PDT is effective in the overall management of oral premalignant lesions.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Erythro-leukoplakia; Erythroplakia; Leukoplakia; Oral premalignant lesion; Photodynamic therapy; Verrucous hyperplasia

Mesh:

Substances:

Year:  2014        PMID: 25315968     DOI: 10.1016/j.pdpdt.2014.10.001

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN: 1572-1000            Impact factor:   3.631


  10 in total

1.  Vascular alterations after photodynamic therapy mediated by 5-aminolevulinic acid in oral leukoplakia.

Authors:  Flávia Cristina Perillo Rosin; Ana Rita Ribeiro Barcessat; Giuliana Gadoni Giovanni Borges; Luciana Gonçalves Valente Ferreira; Luciana Corrêa
Journal:  Lasers Med Sci       Date:  2016-12-21       Impact factor: 3.161

Review 2.  Vitamin D and Other Differentiation-promoting Agents as Neoadjuvants for Photodynamic Therapy of Cancer.

Authors:  Edward V Maytin; Tayyaba Hasan
Journal:  Photochem Photobiol       Date:  2020-04-15       Impact factor: 3.421

Review 3.  The Effect of Photodynamic Therapy on Oral-Premalignant Lesions: A Systematic Review.

Authors:  Ruchika Choudhary; Sujatha S Reddy; Ravleen Nagi; Rakesh Nagaraju; Sreekanth P Kunjumon; Ritu Sen
Journal:  J Clin Exp Dent       Date:  2022-03-01

Review 4.  Prospects in the Application of Photodynamic Therapy in Oral Cancer and Premalignant Lesions.

Authors:  Rajan Saini; Nathan V Lee; Kelly Y P Liu; Catherine F Poh
Journal:  Cancers (Basel)       Date:  2016-09-02       Impact factor: 6.639

Review 5.  Versatile Nanoplatforms with enhanced Photodynamic Therapy: Designs and Applications.

Authors:  Kai Yan; Yabin Zhang; Chenglong Mu; Qunna Xu; Xunan Jing; Daquan Wang; Dongfeng Dang; Lingjie Meng; Jianzhong Ma
Journal:  Theranostics       Date:  2020-06-05       Impact factor: 11.556

Review 6.  Functional Polymer Nanocarriers for Photodynamic Therapy.

Authors:  Tuanwei Li; Lifeng Yan
Journal:  Pharmaceuticals (Basel)       Date:  2018-11-30

7.  Primary Clinical Evaluation of Photodynamic Therapy With Oral Leukoplakia in Chinese Patients.

Authors:  Ying Han; Si Xu; Jianqiu Jin; Xing Wang; Xiaodan Liu; Hong Hua; Xiaoyang Wang; Hongwei Liu
Journal:  Front Physiol       Date:  2019-01-22       Impact factor: 4.566

Review 8.  Porphyrin Derivative Nanoformulations for Therapy and Antiparasitic Agents.

Authors:  Daiana K Deda; Bernardo A Iglesias; Eduardo Alves; Koiti Araki; Celia R S Garcia
Journal:  Molecules       Date:  2020-04-29       Impact factor: 4.411

Review 9.  Biophysical Characterization and Anticancer Activities of Photosensitive Phytoanthraquinones Represented by Hypericin and Its Model Compounds.

Authors:  Valéria Verebová; Jiří Beneš; Jana Staničová
Journal:  Molecules       Date:  2020-12-01       Impact factor: 4.411

10.  Phototoxicity of Liposomal Zn- and Al-phthalocyanine Against Cervical and Oral Squamous Cell Carcinoma Cells In Vitro.

Authors:  Jason Young; Michael Yee; Hayoung Kim; Jennifer Cheung; Takahiro Chino; Nejat Düzgüneş; Krystyna Konopka
Journal:  Med Sci Monit Basic Res       Date:  2016-12-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.